3D Scanning and SLA 3D Printing for Manufacturing Topical Drug Delivery Systems Tailored to Individual Patients
- In: Short Communications C2 on Tuesday, 23 May 2017, 11:15-12:30
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: GOYANES, Alvaro (FabRx, London, United Kingdom)
- Co-author(s): Alvaro Goyanes: FabRx, London, United Kingdom
Jie Wang: UCL - School of Pharmacy, London, United Kingdom
Usanee Det-Amornrat: UCL - School of Pharmacy, London, United Kingdom
Abdul Basit: UCL - School of Pharmacy, London, United Kingdom
Simon Gaisford: UCL - School of Pharmacy, London, United Kingdom - Abstract:
Backgrounds
3D printing (3DP) allows the fabrication of solid objects of virtually any shape from a 3D model and 3D scanning technology can be used to obtain 3D models adapted to the morphology of an individual. In stereolithography (SLA) printing, drug-containing solutions can be solidified by the action of a laser beam to create a solid object.
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023